Organisms, Genetically Modified
"Organisms, Genetically Modified" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Organisms whose GENOME has been changed by a GENETIC ENGINEERING technique.
| Descriptor ID |
D030781
|
| MeSH Number(s) |
B05.620
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Organisms, Genetically Modified".
Below are MeSH descriptors whose meaning is more specific than "Organisms, Genetically Modified".
This graph shows the total number of publications written about "Organisms, Genetically Modified" by people in this website by year, and whether "Organisms, Genetically Modified" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2015 | 1 | 1 | 2 |
| 2016 | 0 | 1 | 1 |
| 2017 | 1 | 4 | 5 |
| 2020 | 1 | 1 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Organisms, Genetically Modified" by people in Profiles.
-
Food safety, food security and genetically modified organisms in Africa: a current perspective. Biotechnol Genet Eng Rev. 2021 Apr; 37(1):30-63.
-
Call for More Effective Regulation of Clinical Trials with Advanced Therapy Medicinal Products Consisting of or Containing Genetically Modified Organisms in the European Union. Hum Gene Ther. 2021 10; 32(19-20):997-1003.
-
Temporary derogation from European environmental legislation for clinical trials of genetically modified organisms for coronavirus disease 2019. Cytotherapy. 2021 01; 23(1):10-11.
-
[A race against the clock: creation of SARS-Cov-2 in the laboratory, a month after its emergence!] Med Sci (Paris). 2020 Aug-Sep; 36(8-9):797-802.
-
An Infectious cDNA Clone of SARS-CoV-2. Cell Host Microbe. 2020 05 13; 27(5):841-848.e3.
-
Bioinformatic analysis indicates that SARS-CoV-2 is unrelated to known artificial coronaviruses. Eur Rev Med Pharmacol Sci. 2020 04; 24(8):4558-4564.
-
Adaptive evolution influences the infectious dose of MERS-CoV necessary to achieve severe respiratory disease. Virology. 2018 04; 517:98-107.
-
An A/U-Rich Enhancer Region Is Required for High-Level Protein Secretion through the HlyA Type I Secretion System. Appl Environ Microbiol. 2018 Jan 01; 84(1).
-
Current (Food) Allergenic Risk Assessment: Is It Fit for Novel Foods? Status Quo and Identification of Gaps. Mol Nutr Food Res. 2018 01; 62(1).
-
In-vivo monitoring of infectious diseases in living animals using bioluminescence imaging. Virulence. 2018 01 01; 9(1):28-63.